Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CHEK2 Antikörper

Dieses Anti-CHEK2-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von CHEK2 in WB, IF, IP und FACS. Geeignet für Human.
Produktnummer ABIN7126216

Kurzübersicht für CHEK2 Antikörper (ABIN7126216)

Target

Alle CHEK2 Antikörper anzeigen
CHEK2 (Checkpoint Kinase 2 (CHEK2))

Reaktivität

  • 239
  • 87
  • 73
  • 16
  • 13
  • 7
  • 6
  • 5
  • 4
  • 2
  • 2
  • 1
Human

Wirt

  • 220
  • 22
  • 1
Maus

Klonalität

  • 208
  • 35
Monoklonal

Konjugat

  • 114
  • 11
  • 9
  • 9
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 7
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
Dieser CHEK2 Antikörper ist unkonjugiert

Applikation

  • 204
  • 79
  • 78
  • 71
  • 44
  • 39
  • 33
  • 28
  • 23
  • 21
  • 18
  • 5
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Immunoprecipitation (IP), Flow Cytometry (FACS)
  • Spezifität

    Recognizes a serine/threonine protein kinase that is a required check-point to mediate cell cycle arrest, activation of DNA repair and apoptosis. In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. Also, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors.

    Kreuzreaktivität (Details)

    Human. Predicted to react with Mouse and Rat.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant fragment of human CHEK2 corresponding to protein domain

    Isotyp

    IgG2b
  • Applikationshinweise

    Known_Application: Immunoprecipitation (1-2 μg per 100-500 μg of total protein), Flow Cytometry (1-2 μg/million cells), ,Western Blot (1-2 μg/mL),Immunofluorescence (1-2 μg/mL), ,Optimal dilution for a specific application should be determined.

    Positive_Control: HeLa or HCT 116 cells. Human testis, spleen or colon.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    CHEK2 (Checkpoint Kinase 2 (CHEK2))

    Andere Bezeichnung

    CHEK2

    Hintergrund

    Cds1 homolog, Checkpoint kinase 2, Checkpoint like protein CHK2, CHK2 checkpoint homolog (S. pombe), hCds1, HuCds 1, LFS2, PP1425, RAD53, Rad53 homolog, Serine/threonine protein kinase Chk2,CHEK2
    Cellular localisation: Nucleus.

    Molekulargewicht

    60.91kDa

    Gen-ID

    11200, 291363, 505297

    UniProt

    O96017

    Pathways

    p53 Signalweg, Apoptose, Zellzyklus
Sie sind hier:
Chat with us!